Tag: ProPublica

Nursing homes giving powerful antipsychotics to elderly unnecessarily, government report

Nursing homes giving powerful antipsychotics to elderly unnecessarily, government report

HHS Inspector General faults drug companies for aggressively—and illegally—marketing these products to doctors for treatment of dementia and other off-label uses.

Share
May 10, 2011 | 0 Comments More
Financial ties bind medical societies to drug and device makers

Financial ties bind medical societies to drug and device makers

Professional groups like the Heart Rhythm Society write guidelines on treatments and the use of medical devices, but researchers say their acceptance of sponsorships and grants from drug and device makers poses a conflict of interest that many patients never consider.

Share
May 5, 2011 | 0 Comments More
Critical shortage of army neurologists for U.S. troops in Iraq and Afghanistan

Critical shortage of army neurologists for U.S. troops in Iraq and Afghanistan

The Army is facing a “critical” shortage of neurologists, partly because of recent policy changes designed to improve diagnosis and treatment of mild traumatic brain injuries, according to a new military medical memorandum.

Share
April 13, 2011 | 0 Comments More
Drug companies paid $4.38M to Washington state doctors–Puget Sound Business Journal

Drug companies paid $4.38M to Washington state doctors–Puget Sound Business Journal

With so much money paid to physicians — typically in exchange for public speaking events or professional education seminars for other doctors — medical ethics experts say doctors essentially push drugs or medical devices developed by the drug makers from which they are accepting cash.

Share
November 19, 2010 | 0 Comments More
Cathleen Sharkey holds a frame of photographs of her mother, Barbara Scott, whose bloodline became disconnected during a dialysis treatment at Dutchess Dialysis Center. Scott never fully recovered and died shortly after of heart failure. (Dan Nguyen/ProPublica)

When needles dislodge, dialysis can turn deadly

Dialysis patients die or are hospitalized every year as a result of catastrophic hemorrhages.

Share
November 10, 2010 | 0 Comments More
How one senator has delayed action on formaldehyde

How one senator has delayed action on formaldehyde

Louisiana GOP Sen. David Vitter has pushed the EPA to slow its process of updating a 20-year-old health assessment of formaldehyde.

Share
April 15, 2010 | 0 Comments More
What health care reform means for: ‘Young Invincibles’

What health care reform means for: ‘Young Invincibles’

Last year, 47% of people between age 19 and 34 went without insurance at some point: 1-in-3 is uninsured now.

Share
December 23, 2009 | 0 Comments More
What Health Care Reform Means for: Medicaid Recipients

What Health Care Reform Means for: Medicaid Recipients

Sarah Goodwin, 25, has chronic fatigue syndrome and relies on Medicaid for coverage.

Share
December 8, 2009 | 0 Comments More
What does health reform mean if you have insurance?

What does health reform mean if you have insurance?

The reforms being proposed could put some upward pressure on premiums . . .

Share
December 6, 2009 | 0 Comments More
What health care reform means for: Small Businesses

What health care reform means for: Small Businesses

Fairfield offers insurance to 10 of its 12 employees, at a company cost of $550 per employee each month.

Share
November 9, 2009 | 0 Comments More
See which architects of the 2003 law that created the Medicare prescription drug plan are back on Capitol Hill lobbying for drug companies and fighting healthcare reforms that would cut into the industry’s profits from Medicare. To understand how the pharmaceutical industry is helping to shape the nation’s health care policies, it helps to understand how the industry’s interests prevailed when Part D was created in 2003.  As ideas for the prescription drug benefit were being

The lawmakers and staff who crafted the Medicare drug bill are back – as lobbyists

At least 25 of those key players are back; this time as lobbyists trying to persuade their former colleagues to protect a lucrative deal for drug companies.

Share
October 21, 2009 | 0 Comments More